VYNE Therapeutics Inc. (VYNE)
 NASDAQ: VYNE · Real-Time Price · USD
 0.3664
 +0.0198 (5.71%)
  At close: Oct 30, 2025, 4:00 PM EDT
0.3730
 +0.0066 (1.80%)
  Pre-market: Oct 31, 2025, 4:32 AM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $9.33 million as of October 30, 2025. Its market cap has decreased by -68.36% in one year.
Market Cap 
 9.33M
Enterprise Value 
 -30.29M
1-Year Change 
 -68.36%
Ranking 
 Category 
 Stock Price 
$0.37
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $9.33M, a decrease of -95.94%. That is a compound annual growth rate of -43.31%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 9.33M | -81.11% | 
| Dec 31, 2024 | 49.42M | 51.96% | 
| Dec 29, 2023 | 32.52M | 273.57% | 
| Dec 30, 2022 | 8.71M | -84.05% | 
| Dec 31, 2021 | 54.59M | -79.42% | 
| Dec 31, 2020 | 265.25M | 15.46% | 
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 736.23B | 
| Johnson & Johnson | 449.42B | 
| AbbVie | 401.96B | 
| UnitedHealth Group | 333.14B | 
| AstraZeneca | 255.54B | 
| Novartis AG | 239.27B | 
| Novo Nordisk | 229.86B | 
| Abbott Laboratories | 220.36B |